Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Ibuprofen Arginine Granules Formulations
NCT05737069Phase 1Completed
- Sponsor
- Haleon
- Start
- Apr 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen arginine in pain (2 cohorts), sponsored by Haleon. Primary endpoints: Area Under the Plasma Concentration Time Curve From Time Zero to Last Observed Concentration, Area Under the Plasma Concentration Time Curve From Time Zero to Infinity and 1 more. Started Apr 2023; status: completed.
02
Drugs
ibuprofen arginine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05737069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05737069.